drugset / Trial / NCT04863339

Tranexamic Acid for Blood Loss Minimization in Endoscopic Pituitary Surgery

NCT04863339

RandomizedParallel-groupQuadruple-blindOther

Summary

This trial is to determine the effect of Tranexamic Acid (TXA) on blood loss during endoscopic pituitary surgery. The hypothesis of this study is that TXA will reduce blood loss during surgery compared to a placebo. To answer this hypothesis, the investigators are conducting a randomized controlled trial in which half of participants will receive TXA and half will receive placebo (saline) in a double blind fashion.

Timeline

Start
2022-03
Primary completion
2022-04
Completion
2022-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 1 g

Indications